Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-10-04

FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for amlodipine besylate and benazepril hydrochloride, a fixed-dose combination product manufactured by Lupin Pharmaceuti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine Besylate and Benazepril Hydrochloride (Amlodipine besylate and benazepril hydrochloride)

Snippet

SUPPL AP for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE (AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE)